trending Market Intelligence /marketintelligence/en/news-insights/trending/wpcxbcqsijzk8hbcbdteyq2 content esgSubNav
In This List

The Medicines Co. names Purdue Pharma, Merck executive as CEO

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


The Medicines Co. names Purdue Pharma, Merck executive as CEO

The Medicines Co. has appointed Mark Timney as CEO and board member, effective immediately.

Timney replaces Clive Meanwell, who has been named the company's chief innovation officer. Timney has been CEO and president of Purdue Pharma Inc. since Jan. 27, 2014, and was previously president of Merck & Co. Inc.

Parsippany, N.J.-based The Medicines Co. is a biopharmaceutical company that provides medicines to treat acute and intensive care patients.